Guidance library · 52 questions

GMP storage, mapping and monitoring

What EU GMP, the Orange Guide, Annex 15, Annex 1 and ICH Q1A ask of stores, cold rooms, stability chambers, QC fridges and freezers, and how to evidence it.

Reviewed by Jake Farrow, Managing DirectorLast reviewed 19 October 2026

If you hold a manufacturer's licence, GMP asks you to provide, check and monitor the storage conditions your materials and products need, to qualify the rooms and chambers that hold them, and to keep the records intact for as long as they matter. This guide walks through what that means for stores, cold rooms, stability chambers, QC fridges and ultra-low freezers. The one thing to remember: GMP sets almost no numbers for storage, so every interval, limit and delay you choose needs a written, risk-based reason.

Why it matters

A failed chamber loses data, not just stock

In a warehouse, an excursion puts a batch at risk. In a stability chamber it can also put the evidence behind a marketing authorisation at risk: Chapter 6 normally puts at least one batch a year of every strength and pack on stability (6.32), and the raw data supporting the authorisation has to be kept while it stays in force (Chapter 4, 4.12).

The same goes for QC. A standards fridge or a −80 °C freezer holding retention samples, reference standards or cell therapy starting material is GMP storage, and MHRA inspectors have cited labs with no temperature recording in sample and standard stores.

What the rules say

Law, the GMP Guide, then the Orange Guide

Regulation 37 of the Human Medicines Regulations 2012 makes compliance with GMP a condition of the manufacturer's licence. The detail is the EU GMP Guide (EudraLex Volume 4), which the MHRA reproduces with UK legislation and guidance in the Orange Guide. Under regulation C17, the EU guidelines as they stood at the end of 2020 continue to apply unless the MHRA replaces them; the MHRA's 2020 note says Northern Ireland follows the current EU texts. The MHRA has adopted some later texts for GB, including the 2022 Annex 1, which has applied since 25 August 2023 (MHRA Orange Guide update). For others, such as the 2025 Annex 11 and Chapter 4 drafts, check the MHRA's position before relying on them.

For temperature, five texts do most of the work: Chapter 3 (storage conditions provided, checked and monitored, 3.19; calibration at defined intervals, 3.41), Annex 15 (qualification and requalification), Chapter 6 with ICH Q1A(R2) (stability), Annex 11 (the monitoring system) and Chapter 4 (records). The clause-by-clause summary is on EU GMP and the Orange Guide.

What good looks like

Monitoring an inspector will recognise

Every storage condition in a specification needs a matching monitored limit. The 2016 GMP deficiency examples show the usual mismatches: alarms at 18 °C to 26 °C for products needing 2 °C to 25 °C, a receiving bay with a 32 °C limit and no monitoring, capsule shells kept outside their 35 to 65% RH range, and readings taken twice a day with no max/min data.

Chapter 6 asks for environmental data to be recorded so it can be trended (6.9), which a daily tick cannot do. The HPRA temperature guide, which includes manufacturers in its scope, adds that recording probes should be independent of control probes and sit where mapping found the greatest variability. The monitoring system itself is validated under Annex 11, and the MHRA's data integrity guidance does not accept a vendor's validation in isolation from your own configuration and use. See Annex 11 and the 2025 drafts.

Mapping and requalification

Annex 15 never uses the word mapping. It asks for a lifecycle (URS, DQ, IQ, OQ testing the upper and lower limits, PQ under normal conditions) and then evaluation "at an appropriate frequency", with any fixed period justified (4.1, 4.2). For a temperature-controlled room or chamber, a mapping study empty and loaded is how most sites show those things. WHO Supplement 7 lays out the steps: OQ empty with alarm tests on every notification route, door recovery and power-failure holdover, then PQ loaded.

Nobody gives a GMP interval. WHO uses three years as an example for stores, and ISPE's controlled temperature chamber guide moved from a fixed span to a risk-based review. Change control fills the rest: Annex 15 asks every change to be assessed for its effect on requalification (11.4), and MHRA has cited a storage room reconfigured with no look at its mapping.

Stability chambers to ICH tolerances

ICH Q1A(R2) sets the conditions (for example 25 °C ± 2 °C/60% RH ± 5% RH, 40 °C ± 2 °C/75% RH ± 5% RH, 5 °C ± 3 °C and −20 °C ± 5 °C) and says the chamber should control within them and actual temperature and humidity should be monitored. Short spikes from opening doors are accepted; equipment-failure excursions are assessed and reported if they could affect results; and excursions beyond tolerance for more than 24 hours are described in the study report. Chapter 6 adds that the chambers are qualified and maintained like any other GMP equipment (6.29).

The 24 hours is a reporting line, not a grace period. Neither ICH nor GMP sets alarm limits or delays for a chamber, so they are yours to justify.

Ultra-low freezers, LN2 and cell therapy material

Below −20 °C, ICH treats storage case by case, and GMP sets nothing specific. The same rules apply: conditions from the specification, qualification under Annex 15, calibrated monitoring (3.41) and a plan for failure. WHO Supplement 7 asks qualification to measure how long a store holds temperature in a power cut and how long it takes to recover.

Calibration at these temperatures needs care. Our own UKAS scope reaches −90 °C; liquid nitrogen vapour-phase probes are calibrated through accredited partners. Ask any provider where their accredited range stops.

Worked example

A stability chamber over a weekend

This is an illustrative example; the site, times and readings are invented.

Friday 22:40. A 25 °C/60% RH chamber's humidifier fails. Humidity falls below the 56% alert limit at 23:05, and below the 55% action limit at 23:20. After the 30-minute delay the on-call engineer is alerted at 23:50 and acknowledges at 00:05. What they do: move the trays to the qualified back-up chamber by 01:30, so the excursion lasts about two and a quarter hours. What they record: the alarm, the acknowledgement, the readings and the transfer, in the audit trail.

Monday 09:00. QA opens a deviation. The excursion was caused by equipment failure and lasted under 24 hours, so ICH asks the team to assess the effect and report it only if it could affect results; they record that a short dip in humidity at 25 °C is unlikely to affect the products on test, with the stability lead's reasoning. Change control covers the humidifier repair and asks whether the chamber needs remapping before reuse.

Without monitoring, the same failure would have been found at Monday's pull point, about 58 hours later: past the 24-hour line, in the study report, and a harder conversation with the inspector.

Where it is unclear

Where GMP and GDP differ

Many sites work under both. GDP says map before use and remap on risk or after change; GMP asks for qualification and evaluation at a justified frequency (mapping and requalification). GDP keeps documents at least five years; GMP ties retention to batch expiry, QP certification and the life of the marketing authorisation (retention). GDP alone asks for alarms to be regularly tested and gives a calibration minimum for transport (alarms and calibration).

Inspection findings

What MHRA's GMP data show

MHRA's 2019 GMP deficiency spreadsheet covers 258 inspections and 1,648 deficiencies. Annex 15 was cited in 117 of those inspections, Annex 11 in 95, calibration (3.41) in 41 and storage conditions (3.19) in 38. Most storage and calibration citations were graded Other, with some Majors and no Criticals.

The 2015 and 2016 reports give the detail: a retention sample store with no logger nearby, contractor mapping the company never approved, a standards fridge read weekly with no max/min, and users able to change the default audit trail. MHRA has published no GMP deficiency data since 2019.

MHRA GMP inspections citing each area, 2019
Annex 15 qualification and validation117
Annex 11 computerised systems95
3.41 calibration41
3.19 storage conditions38

Our count from MHRA's 2019 GMP deficiency spreadsheet: 258 inspections. One inspection can cite several areas.

In summary

The short version

  • Treat GMP as a licence condition: regulation 37 makes it law, the EU GMP Guide and the Orange Guide set the detail.
  • Give every storage condition in a specification a monitored, alarmed limit that matches it.
  • Qualify rooms and chambers, then evaluate them every year and remap on a justified interval and after every change.
  • Monitor stability chambers independently of their controllers, and act long before the 24-hour reporting line.
  • Calibrate at defined intervals, and look back to the last good calibration when a probe fails.
  • Validate the monitoring system for your own use; a supplier's pack is evidence, not the whole answer.
  • Keep records for their whole life, and prove each year that archived data still opens.

Manufacturers (GMP)

Questions, answered from the source

Last checked 19 October 2026. Each answer links to its source and says whether it is law, formal guidance or interpretation.

How must retention and reference samples be stored, and for how long?Guidance

The revised Annex 19 (applicable from 24 September 2026) says reference and retention samples of each finished product batch should be kept for at least one year after the expiry date (3.1), stored in line with the guidance on declaration of storage conditions (5.1) and the marketing authorisation, for example refrigerated where relevant (5.2).

What's agreed, and what isn't

MHRA's 2015 GMP deficiency examples include a retention sample store with no temperature logger nearby, and a site with no storage facilities, monitoring devices or procedures for its reference and retention samples. The sample store is often the least watched room on site.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
We make an API. What does GMP Part II say about storage temperature?Guidance

Part II (ICH Q7) says materials should be stored under conditions and for a period that do not adversely affect their quality (7.42). Storage facilities should hold materials under appropriate conditions, for example controlled temperature and humidity when necessary, and records should be kept of those conditions "if they are critical for the maintenance of material characteristics" (10.10). Utilities that could affect quality, such as HVAC, should be qualified and monitored, with action when limits are exceeded (4.20).

What's agreed, and what isn't

Special transport or storage conditions should be on the label (10.22), and carriers must know and follow them (10.23). MHRA's 2016 deficiency examples include an API shipped without temperature monitoring despite needing storage at 25 °C or below.

Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
What does EU GMP actually say about temperature in a manufacturer's warehouse and stores?Guidance

Chapter 3, paragraph 3.19 says storage areas should be clean and dry and maintained within acceptable temperature limits, and where special storage conditions are required (for example temperature or humidity) they "should be provided, checked and monitored". Chapter 5 adds that all materials and products should be stored under the conditions established by the manufacturer (5.7), including intermediates and bulk (5.41), quarantined finished product (5.63) and released stock (5.65).

What's agreed, and what isn't

Chapter 3 never uses the words "mapping" or "alarm". MHRA inspectors have linked 3.19 to mapping in replies on their blog (a mapping study to define where probes go), and paragraph 3.3 extends the same expectation to conditions that could affect equipment. Quarantine, rejected and returned stock need their own marked, segregated areas (3.21, 3.23).

Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
What does GMP expect for QC lab fridges and freezers holding samples, reagents and reference standards?Guidance

Chapter 6 says samples should be protected from adverse storage conditions (6.13), sampling procedures must state storage conditions (6.11), reagents and culture media should be labelled with their storage conditions (6.21) and storage instructions followed (6.22). Chapter 3 asks for adequate storage space for samples and records (3.27).

What's agreed, and what isn't

MHRA deficiency examples show where labs fall short: room temperature not recorded in sample and standard storage areas (2015), and a standards fridge checked only weekly with no max/min readout (2016). Treat a lab fridge holding reference standards like any other GMP storage unit.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
What temperature and humidity does a stability chamber have to hold?Guidance

ICH Q1A(R2) sets the standard conditions. General case: long term 25 °C ± 2 °C/60% RH ± 5% RH or 30 °C ± 2 °C/65% RH ± 5% RH, intermediate 30 °C ± 2 °C/65% RH ± 5% RH, and accelerated 40 °C ± 2 °C/75% RH ± 5% RH. Refrigerated products: long term 5 °C ± 3 °C, accelerated 25 °C ± 2 °C/60% RH ± 5% RH. Frozen: long term −20 °C ± 5 °C. Products stored below −20 °C are treated case by case.

What's agreed, and what isn't

Semi-permeable containers have their own lower-humidity conditions. The tolerances are what the chamber must hold, so your monitoring limits sit inside them. A consolidated ICH Q1 revision was published as a Step 2 draft in April 2025 and was not final when this was checked.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
Does the QP have to consider storage and transport temperatures before certifying a batch?Guidance

Yes. Annex 16, 1.5.3 says conditions of storage and transport for the batch, and for the sample if sent separately, should be taken into account by the QP before certification. For imported batches the QP should be satisfied that the finished product has been stored and transported under the required conditions (1.5.7). Section 3 allows certification after an unexpected deviation only where its impact is evaluated and shown to be negligible.

What's agreed, and what isn't

Section 3 does not mention temperature by name; MHRA's 2016 blog on unexpected deviations applies it to a transit excursion and warns that routinely using stability data to justify excursions would not be acceptable.

Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
Our stability chamber went out of tolerance overnight. Does every excursion have to be reported?Guidance

Not every one. ICH Q1A(R2) says the chamber should be capable of controlling the condition within the defined ranges and the actual temperature and humidity should be monitored. Short spikes from opening doors are "accepted as unavoidable". The effect of excursions due to equipment failure should be addressed, and reported if judged to affect stability results. Excursions beyond the tolerances for more than 24 hours should be described in the study report and their effect assessed.

What's agreed, and what isn't

The 24-hour figure is a reporting threshold for the study, not a delay before you act. Under GMP the excursion is still a deviation in your quality system (Chapter 6, 6.35 for atypical trends). The 2025 draft ICH Q1 carries the same wording into its section 7.1.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
What does the HPRA say we must do after a temperature excursion?Guidance

The HPRA defines an excursion as a deviation from labelled storage conditions 'for any duration of time' in storage or transport. Excursions should be notified immediately to the RP, affected product quarantined until the investigation outcome is known, the manufacturer/MAH consulted on quality impact, the investigation and outcome documented, and corrective actions implemented. If a recall may be required, the HPRA should be notified immediately.

What's agreed, and what isn't

Excursions in fridges or freezers used only to condition ice packs should be investigated with equal thoroughness. The guide does not set a minimum duration below which an excursion can be ignored, which differs from informal commentary elsewhere about very short excursions.

Status
Formal guidance
Applies to
Wholesalers (WDA), Manufacturers, Transport
Last checked
18 October 2026
Can a QP use stability data to certify a batch that had a temperature excursion during import shipping?Interpretation

Possibly, under the Annex 16 'unexpected deviation' route. The MHRA GMP blog gives an example: a product labelled 'store below 25°C' reached 29°C for three days in transit, and stability data showed no issue at 30°C for three months. This could be treated as an unexpected deviation if the shipment process was designed to meet the registered conditions. If shipment conditions were not controlled, routine use of stability data to justify excursions 'would not be acceptable'.

What's agreed, and what isn't

The deviation must be investigated, the root cause found and corrected, and impact shown to be negligible. Repeat occurrences no longer count as 'unexpected'. This route applies to QP certification by manufacturers and importers, not to wholesale RPs.

Source
Handling of unexpected deviations MHRA, 17 June 2016
Status
Interpretation
Applies to
Manufacturers
Last checked
18 October 2026
Annex 1 gives fixed requalification intervals for cleanrooms. Do they apply to our cold rooms too?Guidance

No. Annex 1, 4.32 sets a maximum of 6 months between requalifications for grade A and B areas and 12 months for grade C and D, covering tests such as particle counts and pressure differentials. Those intervals are for classified cleanrooms. Storage areas, cold rooms and chambers fall under Annex 15, which asks for evaluation "at an appropriate frequency" with any fixed period justified (4.1, 4.2).

What's agreed, and what isn't

Because Annex 15 sets no number for storage, your requalification interval is a decision you write down and defend, usually from the risk of the stored product and the trend of the continuous monitoring data.

Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
Do our stability chambers have to be qualified and monitored like any other equipment?Guidance

Yes. Chapter 6, 6.29 says equipment used for the ongoing stability programme, "stability chambers among others", should be qualified and maintained following Chapter 3 and Annex 15. The stability protocol states the storage conditions, using the standard ICH conditions consistent with the label (6.30), and out-of-specification results or significant atypical trends must be investigated (6.35).

What's agreed, and what isn't

ICH Q1A(R2) adds that the actual temperature and humidity should be monitored during stability storage, and that excursions beyond tolerance for more than 24 hours go in the study report. Normally at least one batch a year of each strength and primary pack goes on stability (6.32), so a chamber failure can touch years of data.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
Does Annex 15 require temperature mapping of our cold rooms and stability chambers?Guidance

Annex 15 never uses the word "mapping". It requires facilities, equipment and utilities to be qualified through a lifecycle (URS, DQ, IQ, OQ, PQ), with OQ testing upper and lower operating limits or worst-case conditions (3.11) and PQ under normal operating conditions (3.14). For a temperature-controlled space, a mapping study is the usual way to show those things: that the whole volume holds its range, empty and loaded.

What's agreed, and what isn't

Mapping as a word comes from EU GDP 3.2.1 (map before use, then on risk or after change) and, in sterile manufacture, from Annex 1 for autoclave loads (8.64 and 8.65). Chapter 6, 6.29 says stability chambers must be qualified to Chapter 3 and Annex 15. So the requirement for a chamber is qualification; mapping is the evidence most inspectors expect to see.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
How often do we have to requalify a temperature-controlled room or chamber at a manufacturing site?Guidance

EU GMP Annex 15 sets no fixed interval. It says facilities, equipment and systems should be evaluated "at an appropriate frequency" to confirm they remain in control. Where requalification is done on a time basis, the period should be justified and the evaluation criteria defined, and the possibility of small changes building up over time should be assessed.

What's agreed, and what isn't

WHO Technical Supplement 8 gives an example of remapping every three years, but says a periodic re-evaluation may be more appropriate where several fixed monitors provide continuous data. Whatever interval you choose, document the rationale.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
18 October 2026
In Ireland, does the HPRA expect an ambient warehouse to be mapped in both summer and winter, and empty and full?Guidance

Yes. The HPRA temperature guide (IA-G0011) says warehouses should be mapped in the empty and full states and that mapping should be performed during both summer and winter to assess worst-case conditions. Mapping should be repeated after significant modification to the premises, changes in stock layout or changes to the heating system, and areas such as skylights and controlled drug cabinets should be included.

What's agreed, and what isn't

The guide does not set a fixed re-mapping interval (e.g. every X years); re-mapping is trigger-based. It also flags turning heating off overnight or at weekends as something to consider. The EU GDP Guidelines themselves only say mapping should be done 'under representative conditions'; the explicit summer/winter and empty/full wording is HPRA elaboration.

Status
Formal guidance
Applies to
Wholesalers (WDA), Manufacturers
Last checked
18 October 2026
We moved racking and replaced a compressor in a qualified cold room. Do we need to requalify?Guidance

Annex 15 says changes should be assessed through change control for their impact on product quality, validation, calibration and maintenance, with a plan for any necessary verification or requalification (11.4), and the effectiveness of the change evaluated afterwards (11.7). Requalification at a fixed period must be justified, and gradual change over time should be considered (4.2).

What's agreed, and what isn't

Annex 15 does not list triggers. The HPRA temperature guide, which includes manufacturers in its scope, gives repair or replacement of the refrigeration unit, layout changes and set-point changes as re-mapping triggers, and the MHRA's 2015 GMP deficiency data cite a storage room reconfigured with no assessment of the effect on its mapping.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
What qualification stages does a new cold room, freezer or stability chamber need under GMP?Guidance

Annex 15 sets a lifecycle from the user requirements specification (URS) to retirement. Design qualification checks the design against the URS (3.3). Installation qualification covers installation checks, supplier manuals and calibration of instrumentation (3.9). Operational qualification tests the upper and lower operating limits or worst case (3.11). Performance qualification shows performance under normal operating conditions with worst-case loads (3.14). Tests done at the factory or site acceptance can be credited if transport and installation do not affect the function (3.6).

What's agreed, and what isn't

WHO Supplement 7 describes the same four phases for temperature-controlled stores: OQ empty (alarm tests, empty mapping, door-opening and power-failure tests) and PQ loaded. The monitoring system on the chamber is a separate computerised system, validated under Annex 11.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
When does the HPRA expect a walk-in cold room or large fridge to be re-mapped?Guidance

IA-G0011 says large refrigerators and walk-in cold rooms should be mapped on installation in the empty and full states, with an ambient probe outside the unit. Re-mapping is expected after significant changes such as repair or replacement of the refrigeration unit, changes to internal layout, changes to set points, and changes to how duty/back-up condensers are run, including swapping which is main and which is back-up; if units are routinely rotated, both should be in the mapping study. Moving a small fridge may also require re-mapping.

What's agreed, and what isn't

These are specific triggers that go further in detail than the EU GDP text. The guide's wording varies in strength: re-mapping after a change to how duty/back-up condensers are run 'is required', while moving a fridge 'may' require it, and most other triggers use 'should'. None of it is a legal requirement. No fixed periodic re-mapping frequency is given.

Status
Formal guidance
Applies to
Wholesalers (WDA), Manufacturers
Last checked
18 October 2026
When we qualify a cold room or freezer, which alarm tests should be in the OQ?Guidance

WHO Supplement 7 says OQ is normally done empty and includes alarm tests: at least one high and one low alarm test, plus door-open alarms, and every notification route (sounder, strobe, remote or SaaS service, SMS or phone) needs to be tested. OQ also covers empty mapping for at least 24 hours, door-opening recovery and a power-failure holdover test.

What's agreed, and what isn't

WHO writes for storage and distribution, but the supplement covers ultra-low freezers, freezers, cold rooms and controlled ambient stores, and its steps match the Annex 15 OQ. Do not start PQ until OQ deviations are closed (2.6).

Status
Formal guidance
Applies to
Manufacturers, Laboratories, Wholesalers (WDA)
Last checked
19 October 2026
Do our production areas and WIP stores need temperature mapping, or is monitoring enough?Interpretation

An MHRA group manager, replying on the Inspectorate blog in 2016, said the normal expectation is temperature monitoring only within production areas, but mapping may be required if the product is temperature sensitive. Mapping of WIP or intermediate storage may also be needed to show the routine monitoring positions are representative of the worst case.

What's agreed, and what isn't

This is an inspector's reply, not guidance. EU GMP itself asks for production areas to have temperature control appropriate to the products (Chapter 3, 3.12) and for environmental controls to be recorded (Chapter 5, 5.43). Write the decision, and the data behind it, into your qualification file.

Status
Interpretation
Applies to
Manufacturers
Last checked
19 October 2026
If a contractor carries out our temperature mapping, is their report enough?Interpretation

No; the company has to review and approve it. MHRA's 2015 GMP deficiency examples include mapping of production and warehouse areas by a contractor that "had not been approved by the company". Other findings were a retention sample store with no temperature logger nearby, a drug storage room reconfigured without assessing the impact on the existing mapping, and laboratory sample and standard storage areas with no temperature recording.

What's agreed, and what isn't

WHO Supplement 8 likewise says a protocol prepared by a third party should be authorised by the responsible person in the commissioning organisation. These are deficiency examples, not formal guidance.

Status
Interpretation
Applies to
Manufacturers, Laboratories
Last checked
18 October 2026
Is there an industry standard for how often to remap a controlled temperature chamber?Interpretation

Not a fixed one. ISPE's Good Practice Guide on controlled temperature chambers (second edition, December 2021) moved to a risk-based periodic review, judged on the risk of failing to keep a uniform temperature and how critical the stored product is, "rather than a standard, one-size-fits-all time span". It also covers mapping with load effects, using the data to find worst-case locations and the number of monitoring sensors, and adds ultra-low freezers.

What's agreed, and what isn't

ISPE guides are licensed industry guidance, not regulation; this paraphrases ISPE's public description. It agrees with Annex 15 (an appropriate, justified frequency) and with WHO, which gives three years only as an example.

Status
Interpretation
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
Do we have to trend our temperature and environmental monitoring data, or just check it?Guidance

Chapter 6, 6.9 says some kinds of data, including environmental controls, "should be recorded in a manner permitting trend evaluation", and out-of-trend data investigated. QC must also have environmental monitoring data and calibration records to hand (6.7). Chapter 4 requires procedures and records for environmental monitoring and calibration (4.29) and logbooks for critical equipment (4.31).

What's agreed, and what isn't

A daily tick that a reading was in range does not allow trend evaluation. A continuous electronic record does, provided someone reviews it. Annex 1 goes further for sterile sites (alarm events evaluated for trends, 5.2).

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
Does Annex 1 require temperature and humidity monitoring in cleanrooms, and how does ISO 14644 fit?Guidance

Annex 1 includes temperature, relative humidity and other specific characteristics in the environmental monitoring programme (9.2), and says they should be controlled within ranges that suit the product, process and personnel (9.6). Cleanroom qualification includes a temperature measurement test and a relative humidity test, with the ISO 14644 series as the reference (4.25), and the number of particle sampling locations comes from ISO 14644-1 (4.28).

What's agreed, and what isn't

Annex 1 separates qualification from routine monitoring (4.24). ISO 14644-1 classifies air cleanliness by particle concentration and ISO 14644-2 sets the particle monitoring plan; particle counting is a separate discipline from storage temperature monitoring.

Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
Does the HPRA temperature guide apply to manufacturers in Ireland, or only wholesalers?Guidance

Its scope covers human and veterinary medicinal product manufacturers, wholesalers and transporters in Ireland, and manufacturers of APIs. It says a continuous temperature monitoring system is required for the storage of medicinal products, recording probes should be independent of controlling probes and placed at the greatest variability found by mapping, warehouses mapped empty and full in summer and winter, and probes calibrated at least annually at a minimum of three points.

What's agreed, and what isn't

Its legal basis and much of its wording are written for wholesale (it cites the wholesale regulations and the RP), so present it as HPRA temperature guidance that includes manufacturers, not as a GMP guideline. Irish manufacturers' legal duty to follow GMP is in S.I. No. 539/2007, regulation 10.

Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
In a sterile suite, what does Annex 1 say about monitoring pressure differentials and setting alarm delays?Guidance

Annex 1 (2022), 4.16 says air pressure differences identified as critical should be continuously monitored and recorded, with a warning system that instantly indicates and warns operators of any failure. The warning should not be overridden without assessment, and "where alarm delays are set, these should be assessed and justified within the CCS" (the contamination control strategy). Other pressure differences are recorded at regular intervals.

What's agreed, and what isn't

This is the only place Annex 1 mentions alarm delays. It sets no figure, so the delay is yours to justify. Cleanroom pressure and particle monitoring is usually a dedicated environmental monitoring system rather than a storage monitoring system.

Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
Is the ICH stability guideline changing, and does the draft change what we monitor?Guidance

ICH endorsed a consolidated Q1 guideline as a Step 2 draft on 11 April 2025, to supersede Q1A to Q1F and Q5C. Its section 7.1 repeats the Q1A(R2) wording almost word for word: the equipment should control the condition within the defined ranges and actual temperature and humidity should be monitored, with the same rules on door spikes, equipment failures and excursions over 24 hours.

What's agreed, and what isn't

It is a draft. The ICH work plan targeted Step 4 for November 2026, and Q1A(R2) remains the effective text until adoption. New in the draft: a 30 °C/75% RH long-term option by climatic zone, and a requirement that each excursion outside a labelling claim is handled in the quality system.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
Should the alarm probe go right by the door, since that is where the temperature swings most?Guidance

No. WHO Technical Supplement 6 (section 2.5.2) says monitors "should not be placed in areas where transient events such as a door opening may affect the monitoring and generate an abnormally high number of alarms". Ambient stores are monitored at the seasonal hot and cold spots found in mapping, and cold rooms and freezer rooms at the operational hot and cold spots. If door openings trigger out-of-range alarms too often and that cannot be fixed technically or operationally, for example by limiting door openings, the area should not be used to store product at all.

What's agreed, and what isn't

The HPRA reaches the same place by a different route: IA-G0011 section 10 says probes should be in an appropriate load simulator so that transient rises when the doors are opened during picking do not trigger alarms. EU GDP 3.2.1 and the MHRA mapping blog say only that monitors go at the extremes found by mapping, which some sites read as the door threshold. Record why each probe is where it is, and how it is buffered.

Status
Formal guidance
Applies to
Wholesalers (WDA), Hospitals and wards, Manufacturers, Laboratories
Last checked
19 October 2026
What does the HPRA expect from temperature alarms?Guidance

Where possible, monitoring systems should have alarms that immediately notify relevant personnel. Alarm set points may include alert and action limits (alert limits set so preventive action can be taken before an excursion), and provision should be made for an out-of-hours response. Alarms should be checked regularly at their set points without exposing product to out-of-specification temperatures, with records kept, and alarm nominees trained.

What's agreed, and what isn't

Probes may be placed in a load simulator to avoid nuisance alarms from door openings. For cold rooms, section 3.3 says 'Alarms should be fitted to the unit'. The freezer section (3.4) expects alarms on large and walk-in units and smaller units holding at-risk product; for small fridges an alarm is 'if fitted'. The guide gives no specific test frequency.

Status
Formal guidance
Applies to
Wholesalers (WDA), Manufacturers
Last checked
18 October 2026
What do MHRA GMP inspectors find wrong with alarms and humidity in manufacturing areas?Interpretation

MHRA's 2016 GMP deficiency examples include temperature alarms in manufacturing areas set at 18 °C to 26 °C when some materials and products required 2 °C to 25 °C; temperature and humidity captured only twice a day as spot readings with no max/min data; capsule shells not stored at the manufacturer's recommended 35 to 65% RH in the warehouse; a warehouse receiving area with no temperature monitoring against its 32 °C limit; and users permitted to change the default audit trail.

What's agreed, and what isn't

Examples from one year's dosage-form inspections, published to support self-inspection. They show the pattern: limits that do not match the product, readings that cannot show what happened between checks, and areas nobody thought to monitor.

Status
Interpretation
Applies to
Manufacturers
Last checked
19 October 2026
A monitoring probe failed its calibration. What does GMP say we must do about past readings?Guidance

Part II says critical monitoring equipment should be calibrated to written procedures and a schedule (5.30), with standards traceable to certified standards where they exist (5.31), and calibration status known and verifiable (5.33). Instruments that fail should not be used (5.34), and deviations should be investigated to see whether they could have affected quality since the last successful calibration (5.35).

What's agreed, and what isn't

Part II is written for APIs, but the same look-back is what any GMP inspector will ask about. The HPRA temperature guide, which includes manufacturers in scope, says a failed calibration should trigger a review of previous readings and that calibration should cover the entire monitoring system.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
How often does EU GMP say our temperature probes and recorders must be calibrated?Guidance

Chapter 3, paragraph 3.41 says measuring, weighing, recording and control equipment should be calibrated and checked at defined intervals by appropriate methods, with adequate records kept. It does not set the interval. Annex 15 adds that installation qualification includes calibration of instrumentation (3.9), and change control must consider the effect of a change on calibration (11.4).

What's agreed, and what isn't

An MHRA inspector replying on the Inspectorate blog in 2018 said "the general expectation is that equipment should be calibrated annually", which is interpretation rather than a GMP clause. GDP is firmer for transport: at least once a year (9.2). Whatever interval you choose, justify it from the instrument's history and risk, as ICH Q9(R1) Annex II.4 suggests for calibration schedules.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
What calibration does the HPRA expect for temperature monitoring probes?Guidance

Probes should be calibrated at least annually against a traceable reference, at a minimum of three points across the range of use (examples given: 0, 15 and 30°C for ambient warehouse probes; -10, 0 and 10°C for fridge probes). Calibration should cover the entire monitoring system (probes, receiver, display), certificates should state the method and be reviewed and approved by the wholesaler, and a failed calibration should trigger a review of previous readings.

What's agreed, and what isn't

Auxiliary calibrated probes should be used so storage areas stay monitored during calibration; serial numbers and certificates of these should be kept. Recording probes should have an accuracy of at least +/-0.5°C and be independent of control probes. In IA-G0011 section 3.3 the ±0.5 °C figure applies to large-volume cold storage only; the HPRA's 2022 mapping slides (slide 9) repeat it generally.

Status
Formal guidance
Applies to
Wholesalers (WDA), Manufacturers
Last checked
18 October 2026
How long must batch records for an investigational product be kept?Law

At least five years after the completion or formal discontinuation of the last clinical trial in which the batch was used. For Great Britain the period comes from Commission Directive 2003/94/EC, Article 9(1), which the UK clinical trials regulations still reference; Article 9(2) adds that electronic systems must be validated, data backed up and audit trails maintained. For Northern Ireland, Delegated Regulation 2017/1569, Article 8(3) sets the same five years.

What's agreed, and what isn't

Sample retention for IMPs is two years after the last trial ends (2017/1569, Article 11). Keep the storage and shipping temperature records that support a batch's certification for at least as long as its batch documentation.

Source
Commission Directive 2003/94/EC, Article 9 (Documentation) European Commission, 8 October 2003
Status
Law
Applies to
Manufacturers
Last checked
19 October 2026
Can our QA lead or the person who reviews the data also be the administrator of the monitoring system?Guidance

The MHRA's GxP data integrity guidance says shared logins or generic user access should not be used for systems generating, amending or storing GxP data, and that system administrator rights "should not be assigned to individuals with a direct interest in the data (data generation, data review or approval)" (6.16). Audit trails identified as required should be switched on and users should not be able to amend or switch them off (6.13).

What's agreed, and what isn't

Administrator access should be kept to the fewest people possible for the size of the organisation, each with unique credentials so their actions show in the audit trail. In a cloud system the supplier usually holds platform administration; your own administrator roles still need the same separation.

Status
Formal guidance
Applies to
Manufacturers, Laboratories, Wholesalers (WDA)
Last checked
19 October 2026
How long must a manufacturer keep storage temperature records?Guidance

Chapter 4 does not name temperature records. Batch documentation must be kept for one year after batch expiry or at least five years after QP certification, whichever is longer (4.11). Critical documentation, including raw data relating to validation or stability that supports the marketing authorisation, must be kept while the authorisation is in force (4.12). Records must stay intact and readable for the whole period (4.1, 4.10).

What's agreed, and what isn't

Storage records that support a batch's release fall in practice with its batch documentation, and chamber records behind stability data with the MA-supporting raw data; this is a reading of 4.11 and 4.12, not their words. Longer periods may apply to products such as ATMPs (4.11). For investigational products the batch documentation period is five years after the last trial using the batch ends.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
How long must an API manufacturer keep records, including storage records?Guidance

Part II, 6.13 says records should be kept for at least one year after the batch's expiry date. For APIs with retest dates, records should be kept for at least three years after the batch is completely distributed.

What's agreed, and what isn't

Part II also requires controls to prevent omissions in data, for example "system turned off and data not captured" (5.43), and a back-up system where a breakdown would mean permanent loss of records (5.48). Both apply directly to a monitoring system.

Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
Once our GMP temperature monitoring system is validated, do we need to do anything else to keep it validated?Guidance

Yes. EU GMP Annex 11 requires computerised systems to be periodically evaluated to confirm they remain valid, looking at things like deviations, incidents, upgrades, performance, security and validation status. Backups should be made regularly and restoration checked, stored data checked for accessibility and readability, and audit trails reviewed regularly. Changes, including configuration changes, must go through a defined change procedure, and it should be possible to get clear printed copies of stored data.

What's agreed, and what isn't

Annex 11 sets no fixed interval. The EMA Q&A says the period for re-evaluation should be based on the system's criticality. Annex 11 is EU GMP guidance that continues to be applied in UK GMP. A revised Annex 11 has been in draft, so check for updates.

Source
EudraLex Volume 4, Annex 11: Computerised Systems European Commission, January 2011
Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
18 October 2026
Our monitoring gateway was offline for a weekend and readings are missing. Is that a GMP problem?Guidance

It can be. Part II says computerised systems should have controls to prevent omissions in data, such as a system turned off and data not captured, and a record of any data change (5.43); where a breakdown could permanently lose records, a back-up system should be provided (5.48). Annex 11 asks that data stay accessible throughout the retention period and backups be checked for restoration (7.1, 7.2).

What's agreed, and what isn't

A gap is a deviation to investigate: when it started, whether the sensors buffered readings and backfilled them, and whether the product was at risk. A monitoring system that alarms when a sensor or gateway goes offline turns a silent gap into a prompt to act.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
The monitoring system supplier gave us a validation pack. Is that enough to show the system is validated?Guidance

Not on its own. MHRA says computerised systems must be validated for their intended purpose, and "the acceptance of vendor-supplied validation data in isolation" from your configuration and intended use is not acceptable. Vendor testing done away from your process and IT setup is likely to be functional verification only, and may not meet performance qualification requirements. Vendor documents can feed into your validation, but you still need to show the system works as configured at your site.

What's agreed, and what isn't

How much site testing is needed depends on risk and complexity (MHRA section 4.3). WHO Supplement 6 expects installed monitoring systems to be qualified through IQ, OQ and PQ after a commissioning period. For SaaS systems the supplier may do much of the work, but the user still has to confirm the system meets its own requirements.

Status
Formal guidance
Applies to
Wholesalers (WDA), Manufacturers, Hospitals and wards, Laboratories, Blood, Tissue and mortuary
Last checked
18 October 2026
What GAMP category is a cloud temperature monitoring system?Interpretation

GAMP 5 (second edition, 2022) groups software as infrastructure, tools and IT services, standard system components, configured components, and custom applications and components (categories 1, 3, 4 and 5; category 2 has not been used since 2008). ISPE says categorisation applies to the components that make up a system and the categories should be viewed as a continuum. A configurable monitoring platform is usually assessed as configured (category 4), with any custom interfaces higher.

What's agreed, and what isn't

ISPE stresses that the software category is only one factor in a risk-based approach; the risk of each function to product and data matters more. GAMP 5 is industry guidance, not regulation, though inspectors know it well. Its second edition adds guidance on assessing cloud service providers and SaaS.

Status
Interpretation
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
Do shipments of investigational products to trial sites need temperature monitoring?Guidance

The EU guideline on sponsors' handling and shipping of IMPs (effective 1 January 2023) says temperature monitoring of transport and storage conditions is necessary, the records should be kept and evaluated at delivery, and equipment critical to keeping the required conditions in transit should be qualified. Any deviation during shipment should be recorded and formally investigated with the manufacturer.

What's agreed, and what isn't

This is the EU text, which applies in Northern Ireland. For Great Britain the 2010 Annex 13 asks for shipping to the sponsor's instructions (44) and storage records to be reviewed before transfers between sites. In practice sponsors expect the same evidence either way.

Status
Formal guidance
Applies to
Manufacturers, Transport
Last checked
19 October 2026
What does Annex 15 expect when we ship finished product from the manufacturing site?Guidance

Section 6 says products should be transported in line with the conditions in the marketing authorisation, the label or the product specification file (6.1). Routes should be defined and seasonal variation considered (6.2). A risk assessment should cover delays, failure of monitoring devices, topping up liquid nitrogen and product susceptibility (6.3), and continuous monitoring and recording of critical environmental conditions should be performed "unless otherwise justified" (6.4).

What's agreed, and what isn't

GDP then applies from dispatch: transport loggers calibrated at least once a year (GDP 9.2) and a procedure for excursions. MHRA's 2016 GMP deficiency examples include air shipments with no justification for not having a logger in every pallet.

Status
Formal guidance
Applies to
Manufacturers, Transport
Last checked
19 October 2026
Brexit happened. Which version of the EU GMP Guide applies to a manufacturer in Great Britain?Law

Regulation C17 of the Human Medicines Regulations 2012 lets the MHRA publish its own GMP and GDP guidelines. Until it does, C17(3) says the guidelines published or adopted by the European Commission "as they applied immediately before IP completion day" (31 December 2020) continue to apply. The MHRA's 2020 note on EU guidance says Great Britain uses the versions as they stood at that date, while Northern Ireland uses the current EU versions.

What's agreed, and what isn't

Since 1 January 2025 C17 covers the whole UK (amended by the Windsor Framework regulations, SI 2024/832), and no later gov.uk page restates the GB and Northern Ireland split for GMP guidelines. In practice the MHRA still points manufacturers to EudraLex Volume 4 and the Orange Guide, which Pharmaceutical Press updated in 2026 for the revised Annex 19. Texts adopted after 2020, such as the 2022 Annex 1, are a point to confirm with your inspector if you rely on a GB-only reading.

Status
Law
Applies to
Manufacturers
Last checked
19 October 2026
What makes GMP a legal requirement for a manufacturer in Ireland?Law

The Medicinal Products (Control of Manufacture) Regulations 2007 (S.I. No. 539/2007), regulation 10(1), says a manufacturing authorisation holder must not manufacture medicinal products except in line with Schedule 2 and the principles and guidelines of GMP in the GMP Directive (Commission Directive 2003/94/EC). Schedule 2 requires premises, installations and equipment for handling, storage and distribution necessary to maintain product quality.

What's agreed, and what isn't

This is the regulation as made; later amendments implementing the EU's replacement GMP directive were not checked here. The HPRA inspects against the EU GMP Guide and grades deficiencies as critical, major or other, as the MHRA does.

Status
Law
Applies to
Manufacturers
Last checked
19 October 2026
How much effort should go into the risk assessment behind our monitoring, mapping and calibration decisions?Guidance

ICH Q9(R1) says the effort, formality and documentation of quality risk management should be commensurate with the level of risk, and risk evaluation should be based on scientific knowledge and link to protecting the patient. Formality is not binary, and "resource constraints should not be used to justify the use of lower levels of formality". Its Annex II gives uses that fit monitoring directly: setting calibration and maintenance schedules, the extent of qualification, and the adequacy of storage and transport conditions.

What's agreed, and what isn't

Q9(R1) also asks for subjectivity to be managed and for decisions to rest on relevant data, so a requalification interval backed by trend data from continuous monitoring is easier to defend than one chosen by habit.

Status
Formal guidance
Applies to
Manufacturers, Laboratories, Wholesalers (WDA)
Last checked
19 October 2026
If we outsource mapping, calibration or monitoring, who is responsible when it goes wrong?Guidance

You are. ICH Q10, 2.7 says the pharmaceutical company is ultimately responsible for processes that assure control of outsourced activities, with a written agreement between contract giver and acceptor. Management review should include feedback on outsourced activities (4.1), and deviations go through CAPA with effort proportionate to risk (3.2.2).

What's agreed, and what isn't

MHRA's 2015 GMP deficiency examples include mapping by a contractor that the company had not approved. Approve the protocol before the study, review and approve the report, and audit the supplier. For a monitoring platform, Annex 11 asks for formal agreements with suppliers and service providers (clause 3).

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
We make or store investigational medicinal products. Which GMP rules apply in Great Britain and Northern Ireland?Guidance

Since the amended UK clinical trials regulations took effect on 28 April 2026, the MHRA says GMP for IMPs means the principles in Commission Directive 2003/94/EC for Great Britain and Commission Delegated Regulation 2017/1569 for Northern Ireland. The MHRA says separate GB guidelines for IMPs, intended to reflect the 2010 EU Annex 13, will be published in their own document.

What's agreed, and what isn't

Until that GB guide appears, the 2010 Annex 13 is the reference for GB: it asks the QP to verify conditions of storage and shipment (40) and for storage records at the original site to be reviewed before a transfer between trial sites (47). The MHRA page cites "Directive (EU) 2017/1559", which appears to be a typo.

Status
Formal guidance
Applies to
Manufacturers, Transport
Last checked
19 October 2026
What is the Orange Guide, and is it different from the EU GMP Guide?Guidance

The Orange Guide is the MHRA's compilation "Rules and Guidance for Pharmaceutical Manufacturers and Distributors", published by Pharmaceutical Press. Its publisher describes it as the single source of European and UK guidance and UK legislation on the manufacture and distribution of medicines, including the EU GMP Guide as applied in the UK, the Qualified Person code of practice and guidance on investigational medicines. The Green Guide is the separate book for distributors (GDP).

What's agreed, and what isn't

It reproduces the EU GMP texts rather than replacing them, so the clauses you cite (for example Chapter 3, 3.19) are the same. The MHRA's GMP page lists the 2022 Orange and Green Guides; the Orange Guide is now sold as an online subscription and was updated in 2026 for Annex 19. The 2017 edition added an MHRA section on temperature control and monitoring.

Source
The MHRA Orange Guide (Pharmaceutical Press) MHRA, 24 September 2026
Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
How often do MHRA GMP inspectors actually cite storage temperature and calibration?Interpretation

In MHRA's published 2019 GMP deficiency data, covering 258 inspections and 1,648 deficiencies, Chapter 3, 3.19 (storage conditions provided, checked and monitored) was cited in 38 inspections and 3.41 (calibration) in 41. Annex 11 (computerised systems) was cited in 95 inspections and Annex 15 (qualification and validation) in 117. In the 2018 data (286 inspections) the figures were 49 for 3.19, 49 for 3.41, 87 for Annex 11 and 154 for Annex 15.

What's agreed, and what isn't

These are our counts from MHRA's spreadsheets, which record each EU GMP clause cited; one inspection can cite a clause more than once. Most 3.19 and 3.41 citations were graded Other, with some Majors and no Criticals. MHRA has published no GMP deficiency data after 2019. The 2019 summary ranks 3.41 eighth and 3.19 ninth among the most cited clauses in 2017.

Status
Interpretation
Applies to
Manufacturers
Last checked
19 October 2026
What temperature monitoring problems do MHRA GMP inspectors actually find at manufacturers?Interpretation

MHRA's 2016 GMP deficiency examples include: alarm limits wider than the product storage range; temperature and humidity captured only as twice-daily spot readings with no max/min data; no acceptance criteria for external calibration of warehouse probes; a receiving area not monitored against its limit; API shipped without temperature monitoring or control; and a standards fridge checked only weekly with no max/min readout. Import findings included no justification for not having a logger in every air-freight pallet, and procedures allowing mean kinetic temperature to assess excursions without investigating the cause.

What's agreed, and what isn't

These are examples from one year's dosage-form inspections, published to support self-inspection, not new requirements. More recent MHRA GMP deficiency datasets are summary-level and do not give comparable temperature examples.

Status
Interpretation
Applies to
Manufacturers, Laboratories
Last checked
18 October 2026

20-minute compliance check

How would you answer an inspector on temperature?

In 20 minutes we go through monitoring, alarms, mapping, calibration and excursions with you. You get the gaps in writing. No product tour.